212 related articles for article (PubMed ID: 26738673)
1. Pulmonary Artery Denervation Attenuates Pulmonary Arterial Remodeling in Dogs With Pulmonary Arterial Hypertension Induced by Dehydrogenized Monocrotaline.
Zhou L; Zhang J; Jiang XM; Xie DJ; Wang JS; Li L; Li B; Wang ZM; Rothman AMK; Lawrie A; Chen SL
JACC Cardiovasc Interv; 2015 Dec; 8(15):2013-2023. PubMed ID: 26738673
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary artery denervation improves pulmonary arterial hypertension induced right ventricular dysfunction by modulating the local renin-angiotensin-aldosterone system.
Liu C; Jiang XM; Zhang J; Li B; Li J; Xie DJ; Hu ZY
BMC Cardiovasc Disord; 2016 Oct; 16(1):192. PubMed ID: 27724864
[TBL] [Abstract][Full Text] [Related]
3. Sympathetic innervation of canine pulmonary artery and morphometric and functional analysis in dehydromonocrotaline-induced models after pulmonary artery denervation.
Jiang X; Zhang J; Zhou L; Luo J; Wang J; Li L; Chen S
Interact Cardiovasc Thorac Surg; 2020 Nov; 31(5):708-717. PubMed ID: 33057705
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension).
Chen SL; Zhang FF; Xu J; Xie DJ; Zhou L; Nguyen T; Stone GW
J Am Coll Cardiol; 2013 Sep; 62(12):1092-1100. PubMed ID: 23850902
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Artery Denervation: Update on Clinical Studies.
Zhang H; Chen SL
Curr Cardiol Rep; 2019 Sep; 21(10):124. PubMed ID: 31486924
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary Artery Denervation Significantly Increases 6-Min Walk Distance for Patients With Combined Pre- and Post-Capillary Pulmonary Hypertension Associated With Left Heart Failure: The PADN-5 Study.
Zhang H; Zhang J; Chen M; Xie DJ; Kan J; Yu W; Li XB; Xu T; Gu Y; Dong J; Gu H; Han Y; Chen SL
JACC Cardiovasc Interv; 2019 Feb; 12(3):274-284. PubMed ID: 30732732
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.
Chen SL; Zhang YJ; Zhou L; Xie DJ; Zhang FF; Jia HB; Wong SS; Kwan TW
EuroIntervention; 2013 Jun; 9(2):269-76. PubMed ID: 23466961
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.
Chen SL; Zhang H; Xie DJ; Zhang J; Zhou L; Rothman AM; Stone GW
Circ Cardiovasc Interv; 2015 Nov; 8(11):e002837. PubMed ID: 26553699
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter radiofrequency pulmonary artery denervation in swine: the evaluation of lesion degree, hemodynamics and pulmonary hypertension inducibility.
Goncharova NS; Condori Leandro HI; Vakhrushev AD; Koshevaya EG; Skorik YA; Mitrofanova LB; Murashova LA; Korobchenko LE; Andreeva EM; Lebedev DS; Moiseeva OM; Mikhaylov EN
BMC Pulm Med; 2021 Dec; 21(1):418. PubMed ID: 34922518
[TBL] [Abstract][Full Text] [Related]
10. Beneficial Effects of Renal Denervation on Pulmonary Vascular Remodeling in Experimental Pulmonary Artery Hypertension.
Qingyan Z; Xuejun J; Yanhong T; Zixuan D; Xiaozhan W; Xule W; Zongwen G; Wei H; Shengbo Y; Congxin H
Rev Esp Cardiol (Engl Ed); 2015 Jul; 68(7):562-70. PubMed ID: 25804321
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
12. Transthoracic Pulmonary Artery Denervation for Pulmonary Arterial Hypertension.
Huang Y; Liu YW; Pan HZ; Zhang XL; Li J; Xiang L; Meng J; Wang PH; Yang J; Jing ZC; Zhang H
Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):704-718. PubMed ID: 30816802
[TBL] [Abstract][Full Text] [Related]
13. [Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension].
Zhang S; Zhao Q; Jiang X; Yang B; Dai Z; Wang X; Wang X; Guo Z; Yu S; Tang Y; Hu W; Huang C
Zhonghua Yi Xue Za Zhi; 2015 Apr; 95(14):1108-12. PubMed ID: 26081215
[TBL] [Abstract][Full Text] [Related]
14. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
Zhang H; Wei Y; Zhang C; Yang Z; Kan J; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Sun J; Zhao C; Zhang J; Yan X; Chen F; Yao C; Stone GW; Chen SL
JACC Cardiovasc Interv; 2022 Dec; 15(23):2412-2423. PubMed ID: 36121246
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
[TBL] [Abstract][Full Text] [Related]
17. The progress of pulmonary artery denervation.
Xie Y; Liu N; Xiao Z; Yang F; Zeng Y; Yang Z; Xia Y; Chen Z; Xiao Y
Cardiol J; 2022; 29(3):381-387. PubMed ID: 33438182
[TBL] [Abstract][Full Text] [Related]
18. Treatment effects of pulmonary artery denervation for pulmonary arterial hypertension stratified by REVEAL risk score: Results from PADN-CFDA trial.
Zhang J; Kan J; Wei Y; Zhang C; Yang Z; Gu H; Fan F; Gu H; Wang Q; Xie D; Zhang G; Guo X; Yin Y; Jin B; Zhou H; Yang Z; Wang Z; Xin Y; Zhang C; Meng L; Wang X; Zhao C; Zhang H; Yan X; Chen F; Yao C; Benza RL; Stone GW; Chen SL
J Heart Lung Transplant; 2023 Aug; 42(8):1140-1151. PubMed ID: 36990173
[TBL] [Abstract][Full Text] [Related]
19. Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study.
Garcia-Lunar I; Pereda D; Santiago E; Solanes N; Nuche J; Ascaso M; Bobí J; Sierra F; Dantas AP; Galán C; San Antonio R; Sánchez-Quintana D; Sánchez-González J; Barberá JA; Rigol M; Fuster V; Ibáñez B; Sabaté M; García-Álvarez A
Basic Res Cardiol; 2019 Jan; 114(2):5. PubMed ID: 30635778
[TBL] [Abstract][Full Text] [Related]
20. [Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].
Gu L; Liu CJ; Xie L; Gu L; Yu L; Liu HM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):821-827. PubMed ID: 36224684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
